Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.
Blood Cancer Journal.
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.
Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.
Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.
Histochemistry and Cell Biology.
Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders - a Study of the International Myeloma Working Group.
Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay.
Clinical Chemistry and Laboratory Medicine.
High‐dose therapy improves the bone remodelling compartment canopy coverage and bone formation in multiple myeloma.
British Journal of Haematology.
Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages.
Clinical Lymphoma Myeloma & Leukemia.